Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1295197.RAuqn5Kqox7QBDdAZcBwvHaY_4RbNJzNL1XeTmVP2ALpc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1295197.RAuqn5Kqox7QBDdAZcBwvHaY_4RbNJzNL1XeTmVP2ALpc130_assertion type Assertion NP1295197.RAuqn5Kqox7QBDdAZcBwvHaY_4RbNJzNL1XeTmVP2ALpc130_head.
- NP1295197.RAuqn5Kqox7QBDdAZcBwvHaY_4RbNJzNL1XeTmVP2ALpc130_assertion description "[At the most recent (5-year) follow-up, the patient was alive with good quality of life and no evidence of metastases.This finding suggests that BPC therapy might be considered a good therapeutic option for the treatment of metastatic TNBC in a woman with a BRCA2 germline mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295197.RAuqn5Kqox7QBDdAZcBwvHaY_4RbNJzNL1XeTmVP2ALpc130_provenance.
- NP1295197.RAuqn5Kqox7QBDdAZcBwvHaY_4RbNJzNL1XeTmVP2ALpc130_assertion evidence source_evidence_literature NP1295197.RAuqn5Kqox7QBDdAZcBwvHaY_4RbNJzNL1XeTmVP2ALpc130_provenance.
- NP1295197.RAuqn5Kqox7QBDdAZcBwvHaY_4RbNJzNL1XeTmVP2ALpc130_assertion SIO_000772 26496295 NP1295197.RAuqn5Kqox7QBDdAZcBwvHaY_4RbNJzNL1XeTmVP2ALpc130_provenance.
- NP1295197.RAuqn5Kqox7QBDdAZcBwvHaY_4RbNJzNL1XeTmVP2ALpc130_assertion wasDerivedFrom befree-2016 NP1295197.RAuqn5Kqox7QBDdAZcBwvHaY_4RbNJzNL1XeTmVP2ALpc130_provenance.
- NP1295197.RAuqn5Kqox7QBDdAZcBwvHaY_4RbNJzNL1XeTmVP2ALpc130_assertion wasGeneratedBy ECO_0000203 NP1295197.RAuqn5Kqox7QBDdAZcBwvHaY_4RbNJzNL1XeTmVP2ALpc130_provenance.